Proteins and Peptides

04 May 2007 Insmed Announces Promising Results From IPLEX(TM) Phase II Myotonic
04 May 2007 Indevus Announces FDA Approval of SUPPRELIN(R)-LA
03 May 2007 RegeneRx Receives IND to Begin Cardiovascular Clinical Program
02 May 2007 Phosphagenics to commence insulin clinical trial in May
02 May 2007 Spectrum Announces Completion Of Target Enrollment In Ozarelix Phase 2b Trial In Benign Prostate Hypertrophy
01 May 2007 Insmed Releases Positive Results from IPLEX Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
01 May 2007 Sangamo BioSciences Announces Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production
01 May 2007 RegeneRx Cleared to Initiate First Ophthalmic Phase 2 Clinical Trial in Diabetics Undergoing Eye Surgery
01 May 2007 FDA Approves SoloSTAR(R) - A New Prefilled Disposable Insulin Pen For Use With LANTUS(R) In People With Type 1 And Type 2 Diabetes
01 May 2007 Cardiome Announces In-Licensing Agreement with Eli Lilly and Company
01 May 2007 Humate-P(R) Approved to Prevent Excessive Bleeding in Patients with von Willebrand Disease Undergoing Surgery
25 Apr 2007 Beyond biogenerics: the real threats for therapeutic proteins
25 Apr 2007 Allon Therapeutics confirms oral bioavailability of AL-309
25 Apr 2007 Study Shows Ambrilia's Therapeutic Peptide PCK3145 Has Clinical Activity In Metastatic Prostate Cancer Patients
25 Apr 2007 Protox Doses First Patient In Benign Prostatic Hyperplasia Trial Using PRX302
24 Apr 2007 Hemispherx and Armada Health Care enter Agreement to Launch Alferon N Injection(R) via Specialty Pharmacy Network
21 Apr 2007 Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
21 Apr 2007 Cleveland BioLabs Protectan CBLB612 Demonstrates Efficacy in Stimulating Proliferation and Mobilization of Bone Marrow Stem Cells in Primate Model
20 Apr 2007 Aranesp(R) ''145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
19 Apr 2007 Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD. Phase III clinical trial may commence shortly
19 Apr 2007 Viragen Announces European Multiferon(R) Licensing Agreement
18 Apr 2007 Dyax Initiates Confirmatory Phase 3 (EDEMA4) Trial for DX-88 for the Treatment of Hereditary Angioedema
18 Apr 2007 DeveloGen and Andromeda, a newly formed wholly-owned subsidiary of Clal Biotechnology Industries, Sign Term Sheet for Asset Purchase Agreement for the DiaPep277(R) Program
18 Apr 2007 Adnexus Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) on Clinical Product Candidate, CT-322
18 Apr 2007 Prevascar Phase II Results

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top